Infertility associated with adenomyosis. Literature review

Mekan R. Orazov , Lyudmila M. Mikhaleva , Marina B. Khamoshina , Ebecha K. Barinova , Marina V. Tsaregorodtseva , Irina V. Besman , Vafa Yu. Ibragimova

For citation:

Abstract

Background. Infertility tends to become one more modern pandemic. According to some estimates, the percentage of infertile couples varies between 10–25% (48–180 million). Such couples face adverse effects on their physical and mental health, financial hardship, serious social stigma, increased risk of domestic violence, and marital instability. Adenomyosis is a common gynecological disorder of unclear etiology that affects female reproductive health. Alterations in endometrial function and susceptibility that are associated with adenomyosis negatively affect the reproductive potential. Current treatments have not achieved good results in combating infertility, that is why it is extremely important to study the causes of infertility, and the review of current research in this area seems relevant.

Aim. To explore etiology and pathogenesis of infertility associated with adenomyosis by reviewing scientific papers.

Results. The review addresses mechanisms underlying the development of infertility associated with adenomyosis and treatment options.

Key words: infertility, adenomyosis.

References

1. Centers for Disease Control and Prevention. The main statistics of the National Family Growth Survey are listing I. Retrieved 28 April 2020. https://www.cdc.gov/nchs/nsfg/key_statistics/i_2015- 2017.htm#infertility

2. World Health Organization Infertility. https://www.who.int/newsroom/fact-sheets/detail/infertility (accessed 11.07.2022)

3. Эседова А.Э., Меджидова А.М. Аденомиоз и бесплодие. Подходы к лечению. РМЖ. Мать и дитя. 2021; 2. https://cyberleninka.ru/article/n/adenomioz-i-besplodie-podhody-k-lecheniyu (дата обращения: 30.01.2023). [Esedova A.E., Medzhidova A.M. Adenomioz i besplodie. Podkhody k lecheniiu. RMZh. Mat' i ditia. 2021; 2. https://cyberleninka.ru/article/n/adenomioz-i-besplodie-podhody-k-lecheniyu (data obrashcheniia: 30.01.2023) (in Russian).]

4. Maheux-Lacroix S, Boutin A, Moore L et al. Hysterosalpingosonography for the diagnosis of tubal occlusion in subfertile women: a systematic review with meta-analysis. Hum Reprod 2014; 29 (5): 953– 63. DOI: 10.1093/humrep/deu 02

5. Khan KN, Fujishita A, Mori T. Pathogenesis of human adenomyosis: current understanding and its association with infertility. J Clin Med 2022; 11 (14): 4057.

6. Munro MG. Classification and reporting systems for adenomyosis. J Min Invasive Gynecol 2020; 27 (2): 296–308.

7. Bulun SE et al. Adenomyosis pathogenesis: insights from next-generation sequencing. Hum Reprod Update 2021; 27 (6): 1086–97.

8. Emge LA. The elusive adenomyosis of the uterus: its historical past and its present state of recognition. Am J Obst Gynecol 1962; 83 (12): 1541–63.

9. Templeman C et al. Adenomyosis and endometriosis in the California Teachers Study. Fertil Steril 2008; 90 (2): 415–24.

10. Jean-Baptiste H et al. Characteristics associated with postoperative diagnosis of adenomyosis or combined adenomyosis with fibroids. Int J Gynecol Obstet 2013; 122 (2): 112–4.

11. Morassutto C et al. Incidence and estimated prevalence of endometriosis and adenomyosis in Northeast Italy: a data linkage study. PloS One 2016; 11 (4): e0154227.

12. Harada T et al. The impact of adenomyosis on women's fertility. Obstet Gynecol Survey 2016; 71 (9): 557.

13. Szubert M et al. Adenomyosis and infertility – review of medical and surgical approaches. Int J Environmental Res Public Health 2021; 18 (3): 1235.

14. Jungwirth A, Giwercman A, Tournaye N et al. Recommendations of the European Association of Urologists on Male infertility: 2012 update. Eur Urol 2012; 62 (2): 324–32.

15. Mavrelos D et al. The impact of adenomyosis on the outcome of IVF– embryo transfer. Reprod BioMed Online 2017; 35 (5): 549–54.

16. Committee of Practice of the American Society of Reproductive Medicine. Management of non-obstructive azoospermia: the conclusion of the committee. Fertil Infertil 2018; 110 (7): 1239–45.

17. Sharma S et al. Does presence of adenomyosis affect reproductive outcome in IVF cycles? A retrospective analysis of 973 patients. Reprod BioMed Online 2019; 38 (1): 13–21.

18. Puente JM et al. Adenomyosis in infertile women: prevalence and the role of 3D ultrasound as a marker of severity of the disease. Reprod Biol Endocrinol 2016; 14 (1): 1–9.

19. Günther V et al. Impact of Adenomyosis on Infertile Patients – Therapy Options and Reproductive Outcomes. Biomed 2022; 10 (12): 3245.

20. Bergeron C, Amant F, Ferenczy A. Pathology and physiopathology of adenomyosis. Best Practice Res Clin Obstet Gynaecol 2006; 20 (4): 511–21.

21. Leyendecker G, Wildt L, Mall G. The pathophysiology of endometriosis and adenomyosis: tissue injury and repair. Arch Gynecol Obstet 2009; 280: 529–38.

22. Sztachelska M et al. Functional Implications of Estrogen and Progesterone Receptors Expression in Adenomyosis, Potential Targets for Endocrinological Therapy. J Clin Med 2022; 11 (15): 4407.

23. Yen CF et al. Molecular characteristics of the endometrium in uterine adenomyosis and its biochemical microenvironment. Reprod Sci 2017; 24 (10): 1346–61.

24. Spencer TE et al. Comparative developmental biology of the mammalian uterus. Cur Topics Dev Biol 2005; 68: 85–122.

25. Khan KN, Fujishita A, Mori T. Pathogenesis of human adenomyosis: current understanding and its association with infertility. J Clin Med 2022; 11 (14): 4057.

26. Hoo PS, Norhaslinda AR, Reza JN. Rare case of leiomyoma and adenomyosis in Mayer-Rokitansky-Kuster-Hauser syndrome. Case Rep Obstet Gynecol 2016; 2016.

27. Schwab KE, Gargett CE. Co-expression of two perivascular cell markers isolates mesenchymal stem-like cells from human endometrium. Hum Reprod 2007; 22 (11): 2903–11.

28. Koike N et al. Pathogenesis and malignant transformation of adenomyosis. Oncol Rep 2013; 29 (3): 861–7.

29. Hufnagel D et al. The role of stem cells in the etiology and pathophysiology of endometriosis. Semin Reprod Med 2015; 33 (5): 333–40.

30. Khan KN, Fujishita A, Mori T. Pathogenesis of human adenomyosis: current understanding and its association with infertility. J Clin Med 2022; 11 (14): 4057.

31. Wilczyński JR et al. Endometriosis Stem Cells as a Possible Main Target for Carcinogenesis of Endometriosis-Associated Ovarian Cancer (EAOC). Cancers 2022; 15 (1): 111.

32. Vannuccini S et al. Pathogenesis of adenomyosis: an update on molecular mechanisms. Reprod Biomed Online 2017; 35 (5): 592–601.

33. Catalanotto C, Cogoni C, Zardo G. MicroRNA in control of gene expression: an overview of nuclear functions. Int J Mol Sci 2016; 17 (10): 1712.

34. Hirakawa T et al. miR-503, a microRNA epigenetically repressed in endometriosis, induces apoptosis and cell-cycle arrest and inhibits cell proliferation, angiogenesis, and contractility of human ovarian endometriotic stromal cells. Hum Reprod 2016; 31 (11): 2587–97.

35. Barrier BF et al. Adenomyosis in the baboon is associated with primary infertility. Fertil Steril 2004; 82: 1091–4.

36. Buggio L et al. Adenomyosis: fertility and obstetric outcome. A comprehensive literature review. Minerva Ginecol 2017; 70 (3): 295– 302.

37. Maubon A et al. Uterine junctional zone at magnetic resonance imaging: a predictor of in vitro fertilization implantation failure. J Obstet Gynaecol Res 2010; 36 (3): 611–8.

38. Senturk LM, Imamoglu M. Adenomyosis: what is new? Women's Health 2015; 11 (5): 717–24.

39. Xiao Y et al. Expression of integrin β3 and osteopontin in the eutopic endometrium of adenomyosis during the implantation window. Eur J Obstet Gynecol Reprod Biol 2013; 170 (2): 419–22.

40. Zeng X et al. NR4A1 is involved in fibrogenesis in ovarian endometriosis. Cell Physiol Biochem 2018; 46 (3): 1078–90.

41. Yao MWM et al. Gene expression profiling reveals progesterone-mediated cell cycle and immunoregulatory roles of Hoxa-10 in the preimplantation uterus. Mol Endocrinol 2003; 17 (4): 610–27.

42. Surrey ES, Minjarez DA, Schoolcraft WB. The incidence of aberrant endometrial αvβ 3 vitronectin expression in a high risk infertility population: could prolonged GnRH agonist therapy play a role? J Assist Reprod Genetics 2007; 24: 553–6.

43. Garcıa P et al. Expression of αv, α4, α5 and β3 integrin subunits, fibronectin and vitronectin in goat peri-implantation. Animal Reprod Sci 2004; 80 (1–2): 91–100.

44. Carrarelli P et al. Expression of inflammatory and neurogenic mediators in adenomyosis: a pathogenetic role. Reprod Sci 2017; 24 (3): 369–75.

45. Benagiano G, Brosens I, Habiba M. Structural and molecular features of the endomyometrium in endometriosis and adenomyosis. Hum Reprod Update 2014; 20 (3): 386–402.

46. Оразов М.Р., Радзинский В.Е., Носенко Е.Н. и др. Иммуновоспалительные предикторы синдрома тазовой боли, связанного с аденомиозом. Гинекология и эндокринология. 2017; 33 (Прил. S1): 44–6. [Orazov M.R., Radzinskii V.E., Nosenko E.N. i dr. Immunovospalitel'nye prediktory sindroma tazovoi boli, sviazannogo s adenomiozom. Ginekologiia i endokrinologiia. 2017; 33 (Pril. S1): 44–6 (in Russian).]

47. Ota H et al. Involvement of catalase in the endometrium of patients with endometriosis and adenomyosis. Fertil Steril 2002; 78 (4): 804–9.

48. Nyachieo A, Siristatidis CS, Vaidakis D. Nonsteroidal anti-inflammatory drugs for assisted reproductive technology. Cochrane Database Sys Rev 2019; 10.

49. Tamura H et al. The clinical outcome of Dienogest treatment followed by in vitro fertilization and embryo transfer in infertile women with endometriosis. J Ovarian Res 2019; 12: 1–9.

50. Hou X et al. The effect of adenomyosis on IVF after long or ultra-long GnRH agonist treatment. Reprod Biomed Online 2020; 41 (5): 845– 53.

51. Younes G, Tulandi T. Effects of adenomyosis on in vitro fertilization treatment outcomes: a meta-analysis. Fertil Steril 2017; 108 (3): 483–90.e3.

52. Cozzolino M et al. The effect of uterine adenomyosis on IVF outcomes: a systematic review and meta-analysis. Reprod Sci 2022; р. 1–17.

53. Maia Jr H et al. Insertion of mirena after endometrial resection in patients with adenomyosis. J Am Assoc Gynecol Laparoscopists 2003; 10 (4): 512–6.

54. Saremi AT et al. Treatment of adenomyomectomy in women with severe uterine adenomyosis using a novel technique. Reprod Biomed Online 2014; 28 (6): 753–60.

55. Colombo N et al. ESMO-ESGO-ESTRO consensus conference on endometrial cancer: diagnosis, treatment and follow-up. Int J Gynecol Cancer 2016; 26 (1).

56. Nirgianakis K et al. Fertility, pregnancy and neonatal outcomes of patients with adenomyosis: a systematic review and meta-analysis. Reprod Biomed Online 2021; 42 (1): 185–206.

57. De Bruijn AM et al. Uterine artery embolization for the treatment of adenomyosis: a systematic review and meta-analysis. J Vasc Int Radiol 2017; 28 (12): 1629–42.e1

For citation:Orazov M.R., Mikhaleva L.M., Khamoshina M.B., Barinova E.K., Tsaregorodtseva M.V., Besman I.V., Ibragimova V.Yu. Infertility associated with adenomyosis. Literature review. Clinical review for general practice. 2023; 4 (3): 34–40. DOI: 10.47407/kr2023.4.3.00219

All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

Clinical review for general practice